I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Isobe, Kazutoshi
109
results:
Search for persons
X
Format
Online (109)
Mediatypes
Articles (Online) (72)
Bookchapter (Online) (1)
OpenAccess-fulltext (36)
Sorted by: Relevance
Sorted by: Year
?
1
Phase II Study of Durvalumab Immediately after Completion o..:
Nakamichi, Shinji
;
Kubota, Kaoru
;
Misumi, Toshihiro
...
Clinical Cancer Research. 30 (2024) 6 - p. 1104-1110 , 2024
Link:
https://doi.org/10.1158/..
?
2
Clinical practice guidelines for molecular tumor marker, 2n..:
Kikuchi, Yoshinori
;
Shimada, Hideaki
;
Yamasaki, Fumiyuki
...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 512-534 , 2024
Link:
https://doi.org/10.1007/..
?
3
Immune checkpoint inhibitors in patients with lung cancer h..:
Isobe, Kazutoshi
;
Nakamura, Yasuhiko
;
Sakamoto, Susumu
...
ERJ Open Research. 10 (2024) 2 - p. 00981-2023 , 2024
Link:
https://doi.org/10.1183/..
?
4
BRCA2‐positive lung adenocarcinoma treated with olaparib: A..:
Motohashi, Takumi
;
Isobe, Kazutoshi
;
Yoshizawa, Takahiro
...
Respirology Case Reports. 12 (2024) 3 - p. , 2024
Link:
https://doi.org/10.1002/..
?
5
Carboplatin and weekly paclitaxel in combination with bevac..:
Omori, Miwako
;
Minegishi, Yuji
;
Uruga, Hironori
...
Respiratory Investigation. 61 (2023) 5 - p. 625-631 , 2023
Link:
https://doi.org/10.1016/..
?
6
ATS/JRS/ALAT Hypersensitivity Pneumonitis Guidelines for Di..:
Sakamoto, Susumu
;
Masuoka, Marie
;
Usui, Yusuke
...
Respiratory Investigation. 61 (2023) 5 - p. 660-667 , 2023
Link:
https://doi.org/10.1016/..
?
7
Entrectinib‐induced syndrome of inappropriate antidiuretic ..:
Kato, Chiaki
;
Sekiya, Muneyuki
;
Sekiguchi, Ryo
...
Respirology Case Reports. 11 (2023) 10 - p. , 2023
Link:
https://doi.org/10.1002/..
?
8
Fixation rate of fiducial gold markers in each segmental br..:
Imasaka, Keisuke
;
Isobe, Kazutoshi
;
Hamanaka, Nobuyuki
.
Respiratory Investigation. 61 (2023) 2 - p. 190-199 , 2023
Link:
https://doi.org/10.1016/..
?
9
First-Line Pembrolizumab Monotherapy for Advanced NSCLC Wit..:
Goto, Yasushi
;
Tamura, Atsuhisa
;
Matsumoto, Hirotaka
...
JTO Clinical and Research Reports. 3 (2022) 9 - p. 100397 , 2022
Link:
https://doi.org/10.1016/..
?
10
Real-world outcomes of chemotherapy for lung cancer patient..:
Minegishi, Yuji
;
Akagami, Tomoe
;
Arai, Makoto
...
Lung Cancer. 172 (2022) - p. 1-8 , 2022
Link:
https://doi.org/10.1016/..
?
11
New risk scoring system for predicting 3-month mortality af..:
Sakamoto, Susumu
;
Shimizu, Hiroshige
;
Isshiki, Takuma
...
Scientific Reports. 12 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
12
Clinicopathological characteristics of colorectal metastase..:
Kikuchi, Yoshinori
;
Shimada, Hideaki
;
Isobe, Kazutoshi
...
International Cancer Conference Journal. 10 (2021) 4 - p. 266-273 , 2021
Link:
https://doi.org/10.1007/..
?
13
Prognostic and functional impact of perioperative LAMA/LABA..:
Azuma, Yoko
;
Sano, Atsushi
;
Sakai, Takashi
...
BMC Pulmonary Medicine. 21 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
14
Pre-Existing Diabetes Limits Survival Rate After Immune Che..:
Hisanaga, Kaori
;
Uchino, Hiroshi
;
Kakisu, Naoko
...
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 14 (2021) - p. 3109-3110 , 2021
Link:
https://doi.org/10.2147/..
?
15
Pre-Existing Diabetes Limits Survival Rate After Immune Che..:
Hisanaga, Kaori
;
Uchino, Hiroshi
;
Kakisu, Naoko
...
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 14 (2021) - p. 773-781 , 2021
Link:
https://doi.org/10.2147/..
1-15